170 related articles for article (PubMed ID: 11936973)
1. Novel integrating adenoviral/retroviral hybrid vector for gene therapy.
Murphy SJ; Chong H; Bell S; Diaz RM; Vile RG
Hum Gene Ther; 2002 Apr; 13(6):745-60. PubMed ID: 11936973
[TBL] [Abstract][Full Text] [Related]
2. A novel, helper-dependent, adenovirus-retrovirus hybrid vector: stable transduction by a two-stage mechanism.
Soifer H; Higo C; Logg CR; Jih LJ; Shichinohe T; Harboe-Schmidt E; Mitani K; Kasahara N
Mol Ther; 2002 May; 5(5 Pt 1):599-608. PubMed ID: 11991751
[TBL] [Abstract][Full Text] [Related]
3. Forced integration of Moloney murine leukemia virus DNA with a mutant integration site occurs through recombination with VL30 DNA.
Murphy JE; Goff SP
Virology; 1994 Oct; 204(1):458-61. PubMed ID: 8091679
[TBL] [Abstract][Full Text] [Related]
4. Isolation and analysis of retroviral integration targets by solo long terminal repeat inverse PCR.
Jin YF; Ishibashi T; Nomoto A; Masuda M
J Virol; 2002 Jun; 76(11):5540-7. PubMed ID: 11991982
[TBL] [Abstract][Full Text] [Related]
5. Targeted transgene insertion into the CHO cell genome using Cre recombinase-incorporating integrase-defective retroviral vectors.
Kawabe Y; Shimomura T; Huang S; Imanishi S; Ito A; Kamihira M
Biotechnol Bioeng; 2016 Jul; 113(7):1600-10. PubMed ID: 26724679
[TBL] [Abstract][Full Text] [Related]
6. A novel self-deleting retroviral vector carrying an additional sequence recognized by the viral integrase (IN).
Torne-Celer C; Moreau K; Faure C; Chebloune Y; Verdier G; Ronfort C
Virus Res; 2008 Jul; 135(1):72-82. PubMed ID: 18420298
[TBL] [Abstract][Full Text] [Related]
7. Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site.
Choulika A; Guyot V; Nicolas JF
J Virol; 1996 Mar; 70(3):1792-8. PubMed ID: 8627702
[TBL] [Abstract][Full Text] [Related]
8. Inclusion of Moloney murine leukemia virus elements upstream of the transgene cassette in an E1-deleted adenovirus leads to an unusual genomic integration in epithelial cells.
Zheng C; O'Connell BC; Baum BJ
Virology; 2003 Sep; 313(2):460-72. PubMed ID: 12954213
[TBL] [Abstract][Full Text] [Related]
9. Genomic integration and gene expression by a modified adenoviral vector.
Zheng C; Baum BJ; Iadarola MJ; O'Connell BC
Nat Biotechnol; 2000 Feb; 18(2):176-80. PubMed ID: 10657124
[TBL] [Abstract][Full Text] [Related]
10. Constructing adenoviral vectors by using the circular form of the adenoviral genome cloned in a cosmid and the Cre-loxP recombination system.
Tashiro F; Niwa H; Miyazaki J
Hum Gene Ther; 1999 Jul; 10(11):1845-52. PubMed ID: 10446924
[TBL] [Abstract][Full Text] [Related]
11. Cre/loxP-mediated excision of a neomycin resistance expression unit from an integrated retroviral vector increases long terminal repeat-driven transcription in human hematopoietic cells.
Fernex C; Dubreuil P; Mannoni P; Bagnis C
J Virol; 1997 Oct; 71(10):7533-40. PubMed ID: 9311833
[TBL] [Abstract][Full Text] [Related]
12. Development of high-titer retroviral producer cell lines by using Cre-mediated recombination.
Vanin EF; Cerruti L; Tran N; Grosveld G; Cunningham JM; Jane SM
J Virol; 1997 Oct; 71(10):7820-6. PubMed ID: 9311869
[TBL] [Abstract][Full Text] [Related]
13. Simplified generation of high-titer retrovirus producer cells for clinically relevant retroviral vectors by reversible inclusion of a lox-P-flanked marker gene.
Loew R; Selevsek N; Fehse B; von Laer D; Baum C; Fauser A; Kuehlcke K
Mol Ther; 2004 May; 9(5):738-46. PubMed ID: 15120335
[TBL] [Abstract][Full Text] [Related]
14. Disclosing the Parameters Leading to High Productivity of Retroviral Producer Cells Lines: Evaluating Random Versus Targeted Integration.
Bandeira VS; Tomás HA; Alici E; Carrondo MJ; Coroadinha AS
Hum Gene Ther Methods; 2017 Apr; 28(2):78-90. PubMed ID: 28301970
[TBL] [Abstract][Full Text] [Related]
15. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
Junker U; Böhnlein E; Veres G
Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
[TBL] [Abstract][Full Text] [Related]
16. Stable transduction of actively dividing cells via a novel adenoviral/episomal vector.
Leblois H; Roche C; Di Falco N; Orsini C; Yeh P; Perricaudet M
Mol Ther; 2000 Apr; 1(4):314-22. PubMed ID: 10933949
[TBL] [Abstract][Full Text] [Related]
17. Self-deleting retrovirus vectors for gene therapy.
Russ AP; Friedel C; Grez M; von Melchner H
J Virol; 1996 Aug; 70(8):4927-32. PubMed ID: 8763996
[TBL] [Abstract][Full Text] [Related]
18. Transgene amplification and persistence after delivery of retroviral vector and packaging functions with E1/E4-deleted adenoviruses.
Torrent C; Jullien C; Klatzmann D; Perricaudet M; Yeh P
Cancer Gene Ther; 2000 Aug; 7(8):1135-44. PubMed ID: 10975674
[TBL] [Abstract][Full Text] [Related]
19. Transient gene expression mediated by integrase-defective retroviral vectors.
Yu SS; Dan K; Chono H; Chatani E; Mineno J; Kato I
Biochem Biophys Res Commun; 2008 Apr; 368(4):942-7. PubMed ID: 18279658
[TBL] [Abstract][Full Text] [Related]
20. Human foamy virus integrase fails to catalyse the integration of a circular DNA molecule containing an LTR junction sequence.
Russell RA; Critchley R; Vassaux G; McClure MO
Gene Ther; 2002 Oct; 9(19):1326-32. PubMed ID: 12224016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
